ENDEXX Corp (OTCMKTS:EDXC) Establishes New Dedicated Medical Marijuana Division

Boston, MA, 04/02/2014 (medicalmarijuanareporter.com) – ENDEXX Corp (OTCMKTS:EDXC) has established a new division dedicated to the business of medical marijuana products in particular medical grade Hemp infused “cannsumables.”. The company will label its proprietary products with the proprietary names “cannsumer good(s), cannsumable(s), and cannsumer(s).” The focus will be on edible delivery systems for medical applications of cannabidiol extracts in the form of Hemp products to be sold in the legal medical marijuana market. The new product line will serve to enhance m3hub’s existing product line of technologies and services. Cannabidiol (Hemp) is a non-psychoactive natural substance that has been shown in various medical studies to possess beneficial properties for the treatment of a wide range of conditions including arthritis, diabetes, MS and epilepsy.

During the past few months, even traditionally conservative states such as Alabama and Georgia have increasingly come to appreciate the medical benefits of marijuana and the active compounds derived from it. Even though these states have not supported the legalization of marijuana for recreational use, they have all introduced bills paving the way for marijuana to be used for medical treatment. ENDEXX Corp (OTCMKTS:EDXC) anticipates that there will be growing demand for different delivery methods and is in the process of establishing the infrastructure necessary for the success of its new division.

It is negotiating for acquiring facilities dedicated to the production of medical grade products and establishing access to legal sources of extracts and products. It is also in the process of identifying and negotiating with potential partners with the required expertise in fields such as foods, botanical products and nutraceuticals. Its CEO has stated that the company is committed to developing state-of-the-art technology and facilities which will meet or exceed the ISO 9000 standards so as to ensure quality and effectiveness. The objective is to develop safe and high quality products at lower than average operating costs. Once again, ENDEXX Corp (OTCMKTS:EDXC) is in the very early stages of the marijuana business and you should ensure caution in handling what is a high risk investment.